This module provides an estimate of the number of diagnosed incident and total prevalent cases of trigeminal neuralgia in the seven major markets using historical trends for the disease and underlying risk factors.
Datamonitor expects to see few diagnosed incident cases of trigeminal neuralgia in all of the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK), with the majority of cases seen in the US and Germany.
The forecast for total prevalent cases of the disease suggests the disease represents a bigger burden for the seven major markets than previously thought. Datamonitor epidemiologists forecast there were approximately 822,200 total prevalent cases of trigeminal neuralgia in the seven major markets in 2011.
Trigeminal neuralgia will continue to be diagnosed rarely in all of the major markets, with 33,000 diagnosed incident cases forecasted in the seven major markets in 2021.